EUCTR2007-006006-22-DE进行中（未招募）不适用
Minimally Invasive Surgery plus rt-PA for ICH Evacuation,MISTIE - MISTIE
Johns Hopkins University, Department of Neurology0 个研究点目标入组 130 人开始时间: 2010年3月8日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Age 18-80
- •2. GCS = 14 or a NIHSS = 6;
- •3. Spontaneous supratentorial ICH = 20cc;
- •4. Symptoms less than 12 hours prior to diagnostic CT scan (an unknown time of symptom onset is exclusionary);
- •5. Intention to initiate surgery within 48 hours after diagnostic CT;
- •6. First dose can be given within 54 hours after diagnostic CT (delays for post surgical stabilization of catheter bleeding or because of unanticipated surgical delay are acceptable with approved waiver from the coordinating center) [Does not apply to Tier 3: ICES];
- •7. Six-hour clot size equal to the most previous clot size + 5 cc (as determined by additional CT scans at least 6 hours apart (A*B*C)/2 method);
- •8. SBP < 200 mmHg sustained for 6 hours recorded closest to the time of randomization;
- •9. Historical Rankin score of 0 or 1;
- •10. Negative pregnancy test.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Infratentorial hemorrhage (any involvement of the midbrain or lower brainstem as demonstrated by radiograph or complete third nerve palsy);
- •2. Patients with platelet count < 100,000, INR > 1.3, or an elevated PT or APTT (reversal of coumadin is permitted but the patient must not require coumadin during the acute hospitalization). Irreversible coagulopathy either due to medical condition or prior to randomization (patient must have a sustained INR = 1.3 using short- and long-acting procoagulants [such as but not limited to NovoSeven, FFP, and/or vitamin K]);
- •3. Clotting disorders;
- •4. Any concurrent serious illness that would interfere with the safety assessments including hepatic, renal, gastroenterologic, respiratory, cardiovascular, endocrinologic, immunologic, and hematologic disease;
- •5. Patients with a mechanical valve;
- •6. Patients with unstable mass or evolving intracranial compartment syndrome;
- •7. Ruptured aneurysm, AVM, vascular anomaly, Moyamoya disease;
- •8. Irreversibly impaired brainstem function (bilateral fixed, dilated pupils and extensor motor posturing), GCS less than or equal to 4;
- •9. Intraventricular hemorrhage requiring external ventricular drainage;
- •10. Internal bleeding, involving retroperitoneal sites, or the gastrointestinal, genitourinary, or respiratory tracts [Does not apply to Tier 3: ICES];
- •11. Superficial or surface bleeding, observed mainly at vascular puncture and access sites (e.g., venous cutdowns, arterial punctures) or site of recent surgical intervention [Does not apply to Tier 3: ICES];
- •12. Known risk for embolization, including history of left heart thrombus, mitral stenosis with atrial fibrillation, acute pericarditis, or subacute bacterial endocarditis [Does not apply to Tier 3: ICES];
- •13. In the investigator’s opinion, the patient is unstable and would benefit from a specific intervention rather than supportive care plus or minus endoscopic or MIS+rtPA removal of the ICH;
- •14. Prior enrollment in the study;
- •15. Any other condition that the investigator believes would pose a significant hazard to the subject if the investigational therapy were initiated;
- •16. Participation in another simultaneous trial of ICH treatment.
研究者
相似试验
进行中（未招募）
不适用
Minimally Invasive Surgery plus rt-PA for ICH Evacuation - MISTIEEUCTR2007-006006-22-GBewcastle upon Tyne Hospitals NHS Trust130
已完成
3 期
Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase IIIIntracerebral HemorrhageNCT01827046Johns Hopkins University499
已完成
2 期
Minimally invasive surgery plus rt-PA for ICH evacuatioStrokeISRCTN50142667Johns Hopkins University (USA)141
尚未招募
Unknown
Implementation of a minimally invasive intervention (MINI) in specialist nephrology practices to strengthen person-centred care for patients with acute kidney injury (AKI), chronic kidney disease (CKD) and end-stage renal disease (ESRD)N17N18Acute renal failureChronic kidney diseaseDRKS00033063Zentrum für Palliativmedizin50
已完成
不适用
Feasibility and safety of minimally invasive R1 vascular surgery for hepatocellular carcinoma: a cohort studyC22Malignant neoplasm of liver and intrahepatic bile ductsDRKS00034789Chirurgische Klinik, Universitätsmedizin Mannheim58